| Lyell Immunopharma Announces Participation in H.C. Wainwright 4th Annual Cell Therapy Virtual Conference |
Globe Newswire |
06/25 |
08:00 |
| NexQloud Elevates Its Distributed Cloud Toward U.S. Defense-Grade Security, Completing SOC 2® Type 2 and Advancing Toward CMMC Level 2 |
Globe Newswire |
06/25 |
08:00 |
| hyperexponential Powers Allianz Commercial's Global Pricing and Underwriting Transformation |
Globe Newswire |
06/25 |
08:00 |
| Baby Innovation Featured Award Winners Announced For 2026 Awards Program |
Globe Newswire |
06/25 |
08:00 |
| TransUnion Report Maps How Mortgage Rate Changes Could Reshape Local Housing Markets |
Globe Newswire |
06/25 |
07:33 |
| Intermap Expands Role in GPS-Denied Navigation with Third DOD Research Contract |
Globe Newswire |
06/25 |
07:30 |
| Onex Partners and Co-Investors to Acquire AirSprint, Canada’s Leader in Fractional Jet Ownership |
Globe Newswire |
06/25 |
07:30 |
| Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer |
Globe Newswire |
06/25 |
07:30 |
| Bombardier and Rolls-Royce Elevate Aircraft Health Monitoring for New and In-Service Global 5500 and 6500 Aircraft, Upgrade Now Available Across Bombardier’s Service Centre Network |
Globe Newswire |
06/25 |
07:30 |
| BriaCell Partners with Uneedle for Scalable Microneedle Administration of Bria-IMT™ |
Globe Newswire |
06/25 |
07:30 |
| Q2 Metals Commences Summer Drill Program and Advances Toward PEA on the Cisco Lithium Project in Quebec, Canada |
Globe Newswire |
06/25 |
07:30 |
| Vivani Medical Receives Regulatory Approval for the Initiation of SLIM-1, a Phase 1 Clinical Trial of NPM-139 Semaglutide Implant in Obesity and Chronic Weight Management |
Globe Newswire |
06/25 |
07:30 |
| Lycia Therapeutics Raises $75 Million in Oversubscribed Financing and Strengthens Leadership Team with Appointment of Chief Financial Officer and General Counsel |
Globe Newswire |
06/25 |
07:30 |
| NuCube Energy to Become a Publicly Listed Company Through Business Combination with Launch Two Acquisition Corp. |
Globe Newswire |
06/25 |
07:20 |
| Digital Currency X Technology Enters Into Securities Purchase Agreement for a Private Placement of US$700 Million of Units, Payable in U.S. Dollars or Digital Assets, to Advance Its Digital Asset Treasury Strategy |
Globe Newswire |
06/25 |
07:18 |
| Winnebago Industries Reports Third Quarter Fiscal 2026 Results |
Globe Newswire |
06/25 |
07:00 |
| Troilus Drills 157.5 Metres Grading 0.95 g/t AuEq While Targeting Inferred Material Within the Z87 Reserve Pit |
Globe Newswire |
06/25 |
07:00 |
| INmune Bio Inc. Achieves MHRA Approval of PIP for CORDStrom™ |
Globe Newswire |
06/25 |
07:00 |
| Lithium Ionic Advances Construction Readiness at Bandeira; Secures Construction-Phase Water Access and Provides Engineering and Procurement Updates |
Globe Newswire |
06/25 |
07:00 |
| Kymera Therapeutics Completes Enrollment in the Phase 2b BROADEN2 Trial of KT-621 in Atopic Dermatitis with Topline Data by Year-end 2026 |
Globe Newswire |
06/25 |
07:00 |
| Highlander Silver: Comprehensive Geophysical Program Maps Extensive System Concealed by Shallow Cover at Corani |
Globe Newswire |
06/25 |
07:00 |
| Tiziana Announces Last Patient Successfully Dosed in its Phase 2 INFORM-MS Trial |
Globe Newswire |
06/25 |
07:00 |
| Initial Lightbridge Fuel™ Material Samples Removed from Idaho National Laboratory’s Advanced Test Reactor |
Globe Newswire |
06/25 |
07:00 |
| Seres Therapeutics to Host Webcast on July 8, 2026, to Discuss Results of Investigator-Sponsored Trial of Seres’ SER-155 in Immune Checkpoint Inhibitor-Related Enterocolitis |
Globe Newswire |
06/25 |
07:00 |
| AnaCardio´s Phase 1b/2a GOAL-HF1 study in patients with Heart Failure and Reduced Ejection Fraction (HFrEF) published in The Lancet |
Globe Newswire |
06/25 |
07:00 |
